ABNORMAL ERYTHROCYTE CHOLINE TRANSPORT IN PATIENTS WITH CHRONIC-RENAL-FAILURE

被引:14
|
作者
FERVENZA, FC
MEREDITH, D
ELLORY, JC
HENDRY, BM
机构
[1] JOHN RADCLIFFE HOSP, NUFFIELD DEPT CLIN MED, OXFORD OX3 9DU, ENGLAND
[2] CHURCHILL HOSP, RENAL UNIT, OXFORD OX3 7LJ, ENGLAND
[3] UNIV OXFORD, PHYSIOL LAB, OXFORD, ENGLAND
关键词
CHOLINE; DIALYSIS; ERYTHROCYTE; MEMBRANE TRANSPORT; UREMIA;
D O I
10.1042/cs0800137
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Erythrocyte choline transport has been studied in nine patients on maintenance haemodialysis for chronic renal failure, six patients on continuous ambulatory peritoneal dialysis, 31 patients with renal transplants and in nine normal control subjects. 2. The mean maximum rate of choline influx (V(max.), measured at an extracellular choline concentration of 250-mu-mol/1) was 66.7 (SD 14.1) mu-mol h-1 l-1 cells in patients on haemodialysis, 87.8 (SD 18.5) mu-mol h-1 l-1 cells in patients on continuous ambulatory peritoneal dialysis and 30.5 (SD 4.9) mu-mol h-1 l-1 cells in control subjects. The increase in choline flux in patients on haemodialysis and patients on continuous ambulatory peritoneal dialysis compared with control subjects was highly significant (P < 0.001). 3. Renal transplant patients showed variable values for the V(max.) of choline influx (range 17.7-71.7-mu-mol h-1 l-1 cells). The values showed a significant negative correlation with creatinine clearance and this correlation correctly extrapolated to the maximum choline flux in normal subjects and in patients on dialysis. 4. The kinetics of choline transport have been studied in erythrocytes of patients on haemodialysis and control subjects in 'zero-trans' conditions after depletion of intracellular choline. The mean V(max.) in these conditions was 38.4 (SD 4.6) mu-mol h-1 l-1 cells in patients on haemodialysis compared with 14.2 (SD 3.7) mu-mol h-1 l-1 cells in control subjects. The mean K(m) under 'zero-trans' conditions was 19.4 (SD 2.4) mu-mol/l in patients on haemodialysis and 7.4 (SD 1.4) mu-mol/l in control subjects. These differences were significant (P < 0.001).
引用
收藏
页码:137 / 141
页数:5
相关论文
共 50 条
  • [41] CHRONIC-RENAL-FAILURE
    FALLON, K
    JOURNAL OF MEDICAL TECHNOLOGY, 1987, 4 (06): : 230 - 233
  • [42] SYMPATHETIC OVERACTIVITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    CONVERSE, RL
    JACOBSEN, TN
    TOTO, RD
    JOST, CMT
    COSENTINO, F
    FOUADTARAZI, F
    VICTOR, RG
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27): : 1912 - 1918
  • [43] METABOLISM OF AMITRIPTYLINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    SANDOZ, M
    VANDEL, S
    VANDEL, B
    BONIN, B
    HORY, B
    HILLIER, YS
    VOLMAT, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (02) : 227 - 232
  • [44] PHARMACOKINETICS OF IOPENTOL IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    SVALAND, MG
    KOLMANNSKOG, F
    LILLEVOLD, PE
    NORDAL, KP
    RESSEM, L
    BERG, KJ
    ACTA RADIOLOGICA, 1992, 33 (05) : 482 - 484
  • [45] CUTANEOUS ALTERATIONS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    PICO, MR
    LUGOSOMOLINOS, A
    SANCHEZ, JL
    BURGOSCALDERON, R
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1992, 31 (12) : 860 - 863
  • [46] ERYTHROCYTE CATALASE ACTIVITY IN CHRONIC-RENAL-FAILURE PATIENTS AND DONORS IN THE PRESENCE OF METAL-IONS
    MARTINMATEO, MC
    DETORRE, C
    BIOLOGICAL TRACE ELEMENT RESEARCH, 1993, 39 (01) : 49 - 54
  • [47] PRURITUS AND XEROSIS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    NIELSEN, T
    ANDERSEN, KEH
    KRISTIANSEN, J
    DANISH MEDICAL BULLETIN, 1980, 27 (06): : 269 - 271
  • [48] MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    LOVE, JW
    JAHNKE, EJ
    MCFADDEN, RB
    MURRAY, JJ
    LATIMER, RG
    GEBHART, WF
    FREIDELL, HV
    FISHER, MB
    URQUHART, RR
    GREDITZER, A
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1980, 79 (04): : 625 - 627
  • [49] SONOCLOT ANALYSIS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    PIVALIZZA, EG
    HARVEY, A
    ABRAMSON, DC
    KING, F
    ANESTHESIOLOGY, 1995, 83 (3A) : A89 - A89
  • [50] FREQUENCY OF AUTOANTIBODIES IN CHRONIC-RENAL-FAILURE PATIENTS
    MAJOR, P
    HORSBURGH, T
    VEITCH, PS
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 777 - 777